We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Hands Philips Lengthy Warning for CAPA, GMP Issues
FDA Hands Philips Lengthy Warning for CAPA, GMP Issues
July 7, 2011
Philips Medical Systems, a subsidiary of imaging devicemaker Philips Healthcare, was cited for various GMP shortfalls, including corrective and preventive action (CAPA) issues, in a recent FDA warning letter.